GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.

DEFINITIVE CONTRACT won by MINISTRY OF DEFENCE
$5,630,591
RecipientMINISTRY OF DEFENCE UEI U6LDUQKZ2CS8
Award IDHDTRA124C0008
Award amount$5,630,591
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Defense — Defense Threat Reduction Agency
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAC32
Set-asideUnrestricted
Start dateJun 10, 2024
End dateJun 9, 2027
Place of performance—
Record updatedMay 18, 2026

View the official award record

More awards won by MINISTRY OF DEFENCE

CWB KITS & SHIPPING FIXTURE
Department of Defense · $9,139,900 · Sep 17, 2024
NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS
Department of Defense · $6,400,449 · Sep 28, 2022
BASE PERIOD IGF::OT::IGF
Department of Defense · $4,402,389 · Oct 31, 2016
HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)
Department of Defense · $2,758,080 · Dec 10, 2018
DEVELOPMENT OF AN INHALATION MODEL OF EEEV IN THE COMMON MARMOSET.
Department of Defense · $1,419,434 · Nov 7, 2019

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids